Extended-Release Drugs Could Be Costing U.S. Healthcare System Billions

By Reuters
NYT U.S.
If doctors prescribed short-acting medications that must be taken twice a day instead of once-a-day extended-release versions, billions in healthcare costs could be saved, a new study suggests.
Published date: February 29, 2020 at 06:05PM
Reuters
New York Times article